Home / Health / Cancer Diagnosis Revolutionized by Liquid Biopsy Workshop
Cancer Diagnosis Revolutionized by Liquid Biopsy Workshop
8 Oct
Summary
- Workshop focused on liquid biopsy for cancer diagnostics and research.
- Participants gained hands-on experience with cfDNA/cfRNA extraction and ddPCR.
- IMS-BHU aims to expand its cancer research with new advanced labs.
A significant national workshop focused on advancing cancer diagnostics through liquid biopsy recently concluded at the Institute of Medical Sciences (IMS), Banaras Hindu University (BHU). The two-day event, titled 'Decoding Cancer through Liquid Biopsy: A Hands-on Workshop from cfDNA/cfRNA Extraction to ddPCR Data Interpretation,' was organized by the DIAMOnDS Centre, IMS-BHU.
Participants received practical training in cutting-edge liquid biopsy techniques, covering cfDNA and cfRNA extraction, the ddPCR workflow, and data analysis for cancer diagnostics and research. The workshop also facilitated discussions and demonstrations, merging theoretical knowledge with practical application of these novel technologies.
During the event, four researchers were honored for their significant contributions to translational oncology. BHU Vice-Chancellor Prof. Ajit Kumar Chaturvedi emphasized the progress in cancer research and the rise of rapid, minimally invasive diagnostic methods using bodily fluids, though solid biopsies remain definitive for diagnosis.
IMS Director Prof. S.N. Sankhwar noted the participation of approximately 50 delegates in the wet-lab training and data interpretation sessions. The Head of Surgical Oncology, Prof. Manoj Pandey, highlighted IMS-BHU's growing emphasis on precision and translational oncology, with plans for a new 3D cell culture lab and advanced AI research capabilities.
